Cover Image

IL36RN mutations in Chinese patients with acute generalized exanthematous pustulosis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Zhongtao Li, Yongping He, Sheng Wang
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	International Journal of Dermatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lower extremity purpura as an uncommon presentation of acute generalized exanthematous pustulosis (AGEP)
by: Christeebella O. Akpala, et al.
Published: (2024)

Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management
by: F. Tetart, et al.
Published: (2024)

Evaluation of hematological inflammatory parameters in patients with palmoplantar pustulosis
by: Xin Ning, et al.
Published: (2024)

Immunohistochemical evaluation of keratins and involucrin in differentiating between palmoplantar pustulosis and pompholyx
by: Dong Y. Oh, et al.
Published: (2024)

A case of revertant mosaic‐like normal‐looking spots in a patient with erythroderma with IL36RN and CARD14 heterozygous mutations
by: Maho Matsuo, et al.
Published: (2024)

Correction to “Spesolimab: A Comprehensive Review on the Anti‐ IL ‐36 Receptor Antibody in Dermatology”
Published: (2025)

Generalized acrodermatitis continua of Hallopeau with an IL36RN variant successfully treated with bimekizumab
by: Takenori Yoshikawa, et al.
Published: (2024)

Plaque‐like cutaneous mucinosis in a patient with KRAS ‐mutated giant cell granuloma of the jaw
by: Alexzandra Mattia, et al.
Published: (2024)

Hair Loss Associated With IL ‐17 and IL ‐23 Inhibitors: A Systematic Review
by: Sana Gupta, et al.
Published: (2026)

TYK2 and IL‐23 Pathway Therapies in Psoriasis: Associations With IL‐6, Tryptophan Metabolism, and Depressive Symptoms
by: Lanmei Lin, et al.
Published: (2026)

Non‐Langerhans cell histiocytosis in a patient with an acute myelogenous leukemia relapse: A case report
by: Dana M. Khoury, et al.
Published: (2025)

Successful treatment of hydrarthrosis of the knee with guselkumab in a patient with palmoplantar pustulosis
by: Natsumi Ikumi, et al.
Published: (2024)

Correlation between double‐stranded DNA and acute urticaria
by: Yuanyuan Li, et al.
Published: (2024)

A novel missense pathogenic variant in the CYLD gene in a Chinese family with multiple familial trichoepithelioma
by: Haisheng Huang, et al.
Published: (2024)

Rapid and sustained resolution in generalized pustular psoriasis with IL‐17A inhibitors required high adherence: a 96‐week analysis in a real‐life setting
by: Kun Hu, et al.
Published: (2024)

IL ‐ 17C and Pityriasis Rubra Pilaris: Successful Treatment of Erythroderma With Brodalumab
by: Noé Duperrier‐Ruiz, et al.
Published: (2025)

Guselkumab‐induced paradoxical exacerbation of extra‐palmoplantar lesions in a patient with palmoplantar pustulosis
by: Kinuko Irie, et al.
Published: (2024)

Retrospective study of the clinical significance of the neutrophil‐to‐lymphocyte ratio in 79 patients with palmoplantar pustulosis
by: Tomoya Watanabe, et al.
Published: (2024)

Epidermolytic epidermal nevus on the genitalia caused by a mosaic KRT10 mutation
by: Kathleen Mitch Uy Gomez, et al.
Published: (2024)

Could the IL ‐17 cytokine family be a promising target for the treatment of palmoplantar pustulosis?
by: Ulrich Mrowietz, et al.
Published: (2026)

Risk factors and early detection of joint damage in patients with psoriasis: a case–control study
by: Amin Yao, et al.
Published: (2024)

Successful Discontinuation of Systemic Corticosteroids With Secukinumab in a Pediatric Case of Generalized Pustular Psoriasis Harboring an IL36RN Mutation
by: Yukie Mori, et al.
Published: (2026)

Abrocitinib: a useful treatment option for CARD14‐mutation‐associated atopic dermatitis
by: Fengjie Liu, et al.
Published: (2024)

Leukocytes containing lipid inclusions in congenital ichthyosis without classical Chanarin‐Dorfman mutations
by: Stéphanie Mallet, et al.
Published: (2024)

Targeting IL ‐23 in Generalized Pustular Psoriasis: Clinical Success With Guselkumab in an Elderly Patient With Comorbidities
by: Christina Silaidi, et al.
Published: (2025)

Superior Clinical and Economic Value of IL ‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis
by: Gennaro Marco Falco, et al.
Published: (2026)

Successful Treatment of PAPASH Syndrome With Concomitant FMF Using IL ‐1 Blockade: A Case Report
by: Chiara Moltrasio, et al.
Published: (2025)

Selective IL ‐23 Inhibition in Conventional Treatment‐Refractory Pyoderma Gangrenosum: A Multicenter, Retrospective Study
by: Luca Bettolini, et al.
Published: (2026)

PASH syndrome: A novel MEFV mutation variant with excellent response to adalimumab in a refractory case
by: Hernan Feola, et al.
Published: (2024)

Risk of Cardiovascular Disease and Cancer in Patients Initiating JAK Versus IL‐4/‐13 Inhibitors for Atopic Dermatitis
by: Sizheng Steven Zhao, et al.
Published: (2025)

Mosaic TMEM173 gene mutation R284S leading to STING‐associated vasculopathy with onset in infancy (SAVI)
by: Zhou Yang, et al.
Published: (2024)

Limited Effectiveness of IL ‐17 Inhibitors for Anti‐ TNF ‐Induced Psoriasis in Hidradenitis Suppurativa: A Multicenter Retrospective Study
by: Leonardo Bascón, et al.
Published: (2026)

Omalizumab in Infant Facial Mastocytoma: 36‐Month Efficacy and Safety Study
by: Qingyang Zhao, et al.
Published: (2026)

Amoxicillin‐Triggered Flare of Generalized Pustular Psoriasis in a Patient With Homozygous IL36RN Pathogenic Variant Treated With Spesolimab and Cyclosporin A
by: Koki Morita, et al.
Published: (2025)

Prognostic impact of EGFR and CASP8 gene mutations in cutaneous squamous cell carcinoma: a retrospective multistudy analysis
by: Nilesh Kodali, et al.
Published: (2024)

Disseminated adult xanthogranuloma in association with underlying B‐cell acute lymphoblastic leukemia
by: Aasheen Qadri, et al.
Published: (2024)

Perceptions and impact of patient reviews: a survey of academic dermatologists
by: Rebekah Leigh, et al.
Published: (2024)

Author reply to “regarding “retrospective study of the clinical significance of the neutrophil‐to‐lymphocyte ratio in 79 patients with palmoplantar pustulosis””
by: Tomoya Watanabe, et al.
Published: (2024)

A pediatric case of SAPHO syndrome without palmoplantar pustulosis
by: Masato Ishikawa, et al.
Published: (2025)

308‐nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single‐center real‐world experience of treatment for palmoplantar pustulosis
by: Yoshiko Niimura, et al.
Published: (2024)